Kinetik holdings sees $188 million stock sale by major owner

ISQ Global Fund II GP LLC sold 4,262,090 shares of Kinetik Holdings (KNTK) at $44.16 per share, totaling $188.2 million, reducing their stake to one share. This follows Kinetik's Q1 2025 earnings miss, with EPS at $0.05 versus an expected $0.36 and revenue at $443.26 million versus an expected $477.05 million, though adjusted EBITDA grew 7% year-over-year. Kinetik also secured a $1.6 billion credit facility, and analysts at RBC Capital Markets, Citi, and Goldman Sachs adjusted their price targets, reflecting cautious optimism amid commodity headwinds and growth prospects.

Analysis

Kinetik Holdings Inc. (KNTK) has experienced a significant insider transaction, with ISQ Global Fund II GP LLC and related entities divesting 4,262,090 shares at $44.16 each, totaling approximately $188.2 million, thereby reducing their stake to a nominal single share. This substantial sale occurred amidst Kinetik's recent Q1 2025 earnings report, which fell short of analyst expectations, delivering an EPS of $0.05 against a forecast of $0.36, and revenue of $443.26 million compared to an anticipated $477.05 million. Despite these misses, the company demonstrated resilience with a 7% year-over-year increase in adjusted EBITDA to $250 million and has secured significant financing through a $1.6 billion senior unsecured revolving credit facility and a $1.15 billion term loan. Analyst sentiment is mixed but leans towards cautious optimism: RBC Capital Markets adjusted KNTK's price target to $55, Citi upgraded the stock to Buy while lowering its target to $55, and Goldman Sachs reduced its target to $54, all maintaining positive long-term ratings. These adjustments reflect concerns over commodity headwinds balanced by perceived growth prospects, with Goldman Sachs noting Kinetik's 2025 EBITDA guidance of $1,090 million to $1,115 million. The company, trading at high earnings multiples, offers a notable 7.08% dividend yield, having increased dividends for three consecutive years, and holds a "FAIR" financial health score from InvestingPro.

Key Decisions for Investors

• Investors should carefully evaluate the implications of the substantial insider sale by ISQ Global Fund II GP LLC alongside Kinetik's recent Q1 2025 earnings miss, particularly in light of the company trading at high earnings multiples.
• Consider the contrasting signals of lowered analyst price targets (RBC $55, Citi $55, GS $54) due to commodity headwinds against maintained 'Buy'/'Outperform' ratings, positive adjusted EBITDA growth, and a strong 7.08% dividend yield with a consistent growth history.
• Monitor Kinetik's progress towards its 2025 EBITDA guidance of $1,090-$1,115 million and the strategic deployment of its newly secured $2.75 billion in credit facilities, as these will be key indicators of future performance and ability to navigate market uncertainties.